Wayne H Winegarden

Business & Economics

Wayne Winegarden quoted in Washington Examiner on trade wars

Fears that the President’s Trump’s trade war with China will lead to a recession may have faded from the headlines, but economists say it cannot be discounted. “We’re not expecting a recession anytime soon, but, that said, there are a number of headwinds, ranging from slower growth, trade tensions, a gradual erosion ...
Commentary

Defining a Medicines’ Value versus its Price

When it comes to determining value, the U.S. health care system faces unique challenges. Without a better approach, the twin goals of continued innovation and broad-based drug affordability will be difficult, if not impossible, to maintain. Value assessment models are quickly becoming the approach du jour to overcome these challenges. However, value ...
Health Care

Much-Publicized Report on Financial Returns on Cancer Treatments Contains Significant Flaws and Biases, Finds New PRI Brief

The World Health Organization (WHO) is advocating that the prices of cancer treatments are excessive, but its report that justifies this conclusion contains significant biases that drastically over-estimates the revenues multiple over research and development (R&D) costs, according to a new issue brief released today by the Center for Medical ...
Business & Economics

New Study Finds ESG Funds Underperform Broader Investment Funds Over Long-Term

ESG funds that champion environmental and social causes have historically underperformed funds investing in the broader market over the long-term, so finds a new study released today by California-based, free-market think tank, the Pacific Research Institute. “In recent years, ESG funds have been presented to investors as socially responsible as ...
Blog

NEW STUDY: Costly Regulations Hurt Entrepreneurship, Reform Needed to ‘Break Down Barriers’ for Jobs, Innovation

Costly regulations serve as a barrier to entrepreneurship, small business growth, innovation, and job opportunities to lift people into the middle class, concludes the first paper in a new series from the California-based, free-market think tank, the Pacific Research Institute. Click here to download the first paper in the Breaking ...
Health Care

New PRI Study: Congress Has Some Unfinished Business – Acting to Repeal the Medical Device Tax

The controversial medical device tax hurts doctors, patients and manufacturers and should be repealed by Congress – according a new study released today by the California-based, free-market think tank, the Pacific Research Institute. Click here to download a copy of the study. “As the congressional session winds down, Congress has ...
Business & Economics

New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs

It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States. Recently, U.S. Bernie Sanders has been ...
Business & Economics

Going Broke One City at a Time: Municipal Bankruptcies in America

Municipalities have rarely defaulted on their debt. As a consequence, municipal debt is regarded as having an extremely low risk for investors. There are disconcerting trends developing that may change this historical view. The combination of the weak U.S. economy, high municipal debt levels, and large under-funded pension liabilities coupled ...
Commentary

SPN 2009 Conference: Final Day

Publius Forum, November 4, 2009 The Wednesday session began with a breakfast address by James K. Glassman the former Under Secretary for Public Diplomacy and Public Affairs, U.S. Dept. of State during the George W. Bush administration. He spoke on Internet freedom (as opposed to net neutrality) and expressed his ...
Business & Economics

Wayne Winegarden quoted in Washington Examiner on trade wars

Fears that the President’s Trump’s trade war with China will lead to a recession may have faded from the headlines, but economists say it cannot be discounted. “We’re not expecting a recession anytime soon, but, that said, there are a number of headwinds, ranging from slower growth, trade tensions, a gradual erosion ...
Commentary

Defining a Medicines’ Value versus its Price

When it comes to determining value, the U.S. health care system faces unique challenges. Without a better approach, the twin goals of continued innovation and broad-based drug affordability will be difficult, if not impossible, to maintain. Value assessment models are quickly becoming the approach du jour to overcome these challenges. However, value ...
Health Care

Much-Publicized Report on Financial Returns on Cancer Treatments Contains Significant Flaws and Biases, Finds New PRI Brief

The World Health Organization (WHO) is advocating that the prices of cancer treatments are excessive, but its report that justifies this conclusion contains significant biases that drastically over-estimates the revenues multiple over research and development (R&D) costs, according to a new issue brief released today by the Center for Medical ...
Business & Economics

New Study Finds ESG Funds Underperform Broader Investment Funds Over Long-Term

ESG funds that champion environmental and social causes have historically underperformed funds investing in the broader market over the long-term, so finds a new study released today by California-based, free-market think tank, the Pacific Research Institute. “In recent years, ESG funds have been presented to investors as socially responsible as ...
Blog

NEW STUDY: Costly Regulations Hurt Entrepreneurship, Reform Needed to ‘Break Down Barriers’ for Jobs, Innovation

Costly regulations serve as a barrier to entrepreneurship, small business growth, innovation, and job opportunities to lift people into the middle class, concludes the first paper in a new series from the California-based, free-market think tank, the Pacific Research Institute. Click here to download the first paper in the Breaking ...
Health Care

New PRI Study: Congress Has Some Unfinished Business – Acting to Repeal the Medical Device Tax

The controversial medical device tax hurts doctors, patients and manufacturers and should be repealed by Congress – according a new study released today by the California-based, free-market think tank, the Pacific Research Institute. Click here to download a copy of the study. “As the congressional session winds down, Congress has ...
Business & Economics

New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs

It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States. Recently, U.S. Bernie Sanders has been ...
Business & Economics

Going Broke One City at a Time: Municipal Bankruptcies in America

Municipalities have rarely defaulted on their debt. As a consequence, municipal debt is regarded as having an extremely low risk for investors. There are disconcerting trends developing that may change this historical view. The combination of the weak U.S. economy, high municipal debt levels, and large under-funded pension liabilities coupled ...
Commentary

SPN 2009 Conference: Final Day

Publius Forum, November 4, 2009 The Wednesday session began with a breakfast address by James K. Glassman the former Under Secretary for Public Diplomacy and Public Affairs, U.S. Dept. of State during the George W. Bush administration. He spoke on Internet freedom (as opposed to net neutrality) and expressed his ...
Scroll to Top